NO971350L - Fotodynamisk inaktivering av virus- og bakterielle blod-kontaminanter med halogenerte kumarin- og furokumarin-sensibilisatorer - Google Patents

Fotodynamisk inaktivering av virus- og bakterielle blod-kontaminanter med halogenerte kumarin- og furokumarin-sensibilisatorer

Info

Publication number
NO971350L
NO971350L NO971350A NO971350A NO971350L NO 971350 L NO971350 L NO 971350L NO 971350 A NO971350 A NO 971350A NO 971350 A NO971350 A NO 971350A NO 971350 L NO971350 L NO 971350L
Authority
NO
Norway
Prior art keywords
furocoumarin
sensitizers
viral
photodynamic inactivation
bacterial blood
Prior art date
Application number
NO971350A
Other languages
English (en)
Norwegian (no)
Other versions
NO971350D0 (no
Inventor
Sang Chul Park
Jr Raymond P Goodrich
Nagender Yerram
Samuel O Sowemino-Coker
Matthew S Platz
Brian Aquila
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/311,125 external-priority patent/US5516629A/en
Priority claimed from US08/343,680 external-priority patent/US6251644B1/en
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO971350D0 publication Critical patent/NO971350D0/no
Publication of NO971350L publication Critical patent/NO971350L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO971350A 1994-09-22 1997-03-21 Fotodynamisk inaktivering av virus- og bakterielle blod-kontaminanter med halogenerte kumarin- og furokumarin-sensibilisatorer NO971350L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/311,125 US5516629A (en) 1990-04-16 1994-09-22 Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US08/343,680 US6251644B1 (en) 1990-04-16 1994-11-22 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US08/427,080 US5789601A (en) 1990-04-16 1995-04-21 Method of inactivation of viral and bacterial blood contaminants
US08/461,626 US5869701A (en) 1990-04-16 1995-06-05 Method of inactivation of viral and bacterial blood contaminants
PCT/US1995/012069 WO1996008965A1 (fr) 1994-09-22 1995-09-21 Procede d'inactivation photodynamique de contaminants du sang de nature virale et bacterienne a l'aide de sensibilisants a la coumarine ou la furocoumarine

Publications (2)

Publication Number Publication Date
NO971350D0 NO971350D0 (no) 1997-03-21
NO971350L true NO971350L (no) 1997-05-22

Family

ID=27502002

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971350A NO971350L (no) 1994-09-22 1997-03-21 Fotodynamisk inaktivering av virus- og bakterielle blod-kontaminanter med halogenerte kumarin- og furokumarin-sensibilisatorer

Country Status (5)

Country Link
EP (1) EP0782388A4 (fr)
AU (1) AU691672B2 (fr)
CA (1) CA2199372A1 (fr)
NO (1) NO971350L (fr)
WO (1) WO1996008965A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
CA2221733A1 (fr) * 1995-06-07 1996-12-19 Baxter International Inc. Procede d'inactivation de contaminants viraux et bacteriens dans le sang
DE19853425A1 (de) * 1998-11-19 2000-05-25 Martin Roecken Khellin-Zubereitung und deren Verwendung zur topischen Therapie der Psoriasis, ihrer Subtypen, Sonderformen, sowie zur topischen Therapie von Ekzemen
AUPP751298A0 (en) * 1998-12-04 1999-01-07 Csl Limited Inactivation of non-enveloped viruses
DE10031851B4 (de) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
US8580192B2 (en) 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
EA201790265A1 (ru) 2014-07-23 2017-07-31 Сирус Корпорейшн Способы получения тромбоцит-содержащих продуктов
WO2016057965A1 (fr) 2014-10-10 2016-04-14 Cerus Corporation Compositions et méthodes de traitement de la fièvre hémorragique virale
PT3313418T (pt) 2015-06-26 2024-06-06 Cerus Corp Composições de crioprecipitado e métodos de preparação das mesmas
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
MX2018008359A (es) 2016-01-07 2019-01-31 Cerus Corp Sistemas y métodos para preparación de plaquetas.
CN110573169A (zh) 2017-03-03 2019-12-13 塞鲁斯公司 制备病原体灭活的血小板组合物的试剂盒和方法
WO2019060610A1 (fr) 2017-09-20 2019-03-28 Cerus Corporation Compositions et méthodes d'inactivation de pathogènes de plaquettes
CA3087253A1 (fr) 2017-12-29 2019-07-04 Cerus Corporation Systemes et procedes pour traiter de fluides biologiques
EP3986499A2 (fr) 2019-06-22 2022-04-27 Cerus Corporation Systèmes de traitement de fluides biologiques
CN114269394A (zh) 2019-06-28 2022-04-01 塞鲁斯公司 用于实现生物流体处理装置的系统和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
IL92996A (en) * 1989-01-10 1996-06-18 Bisaccia Emil Photovoltaic compounds as drugs for the treatment of viral infections and a method for the production of vaccines
WO1993014791A2 (fr) * 1992-01-27 1993-08-05 Cryopharm Corporation Procede d'inactivation des contaminants viraux et bacteriens du sang
CA2221733A1 (fr) * 1995-06-07 1996-12-19 Baxter International Inc. Procede d'inactivation de contaminants viraux et bacteriens dans le sang

Also Published As

Publication number Publication date
EP0782388A1 (fr) 1997-07-09
AU3638595A (en) 1996-04-09
NO971350D0 (no) 1997-03-21
AU691672B2 (en) 1998-05-21
WO1996008965A1 (fr) 1996-03-28
CA2199372A1 (fr) 1996-03-28
EP0782388A4 (fr) 2000-03-08

Similar Documents

Publication Publication Date Title
NO971350L (no) Fotodynamisk inaktivering av virus- og bakterielle blod-kontaminanter med halogenerte kumarin- og furokumarin-sensibilisatorer
ZA912842B (en) Method of inactivation of viral and bacterial blood contaminants
NO955291D0 (no) System for viral inaktivering av blod
AU7217794A (en) Method of inactivation of viral and bacterial blood contaminants
DE69516750D1 (de) Selbstfahrender Rollstuhl mit einstellbarem Schwerpunkt und Einzelradaufhängung
DE69132274D1 (de) Methode der bakteriellen attenuierung und impfstoff
ATE349159T1 (de) Antimikrobielle behandlung von herpes simplex viren und anderer infektioser erkrankungen
MA23226A1 (fr) Derives optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-
DE69821796D1 (de) Sterilisation von glucocorticosteroiden
DE69718399D1 (de) Dilatations- und Zentrierungskatheter
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
DK0498122T3 (da) Titandioxider behandlet med estere og fremstilling deraf
DE69411075D1 (de) Medizinische Artikel und Verfahren dafür
MX9100051A (es) Mezcla esterilizante y metodo de esterilizacion
BR9508539A (pt) Derivado de triazina e medicamento
FI965204A (fi) Bromelaiinin lääkekäyttö
DE69705324D1 (de) N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen
DK118995A (da) Hjulnav med affjedring og anvendelse af sådant hjulnav
BR9707348A (pt) Processo e desinfecção de instrumentos médicos sensíveis
NO940810D0 (no) Behandling av virusinfeksjoner
NO955258D0 (no) Medisinsk anvendelse av enzymer
NO975683D0 (no) Fremgangsmåte for inaktivering av virus- og bakterielle-blodkontaminanter
FI956313A (fi) Lejeeringin ja siitä tehtyjen tuotteiden metamorfinen käsittely
IL130160A0 (en) Inactivation of HIV co-receptors as therapy for HIV infection
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application